FRISCO, Texas, Feb. 28, 2024 /PRNewswire/ -- Baird Medical Devices, Inc. ('Baird Medical' or the 'Company'), a leading microwave ablation ('MWA') medical device developer and provider in China and the United States, today announced that it is accelerating its expansion in the United States through senior hires, key partnerships, and capacity building initiatives to support its business..

德克萨斯州弗里斯科，2024年2月28日/PRNewswire/-Baird Medical Devices，Inc.（“Baird Medical”或“Company”）是中国和美国领先的微波消融（MWA）医疗设备开发商和提供商，今天宣布，它正在通过高级招聘、关键合作伙伴关系和能力建设举措加速在美国的扩张，以支持其业务。。

The Company has experienced rapid momentum in the United States during the fourth quarter of 2023, in particular after receiving the U.S. FDA's clearance to market its MWA systems and technology on November 22, 2023.

2023年第四季度，该公司在美国发展迅速，特别是在2023年11月22日获得美国食品和药物管理局（FDA）批准上市其MWA系统和技术之后。

Christian Chilcott has been appointed as Chief Commercial Officer, Americas, to drive growth. A seasoned medical device executive with two decades of industry experience building and operating organizations focused on minimally invasive, interventional procedures in the field of Interventional Radiology, he brings extensive experience in the areas of soft tissue biopsy, oncology, and the peripheral vasculature.

克里斯蒂安·奇尔科特（ChristianChilcott）被任命为美洲首席商务官，以推动增长。他是一位经验丰富的医疗器械高管，拥有二十年的行业经验，专注于介入放射学领域的微创介入手术，在软组织活检，肿瘤学和外周脉管系统领域拥有丰富的经验。

Mr. Chilcott is building a team across the U.S. to support business expansion including recent hires in New York, Louisiana, Texas, Florida, and California..

奇尔科特正在美国各地组建一支团队，以支持业务扩张，包括最近在纽约、路易斯安那、德克萨斯、佛罗里达和加利福尼亚州的招聘。。

'I am very excited to join Baird Medical at this critical time,' said Christian Chilcott, Chief Commercial Officer, Americas, of Baird Medical. 'It is essential that this market understands what makes MWA superior, safe, and the preferred choice of procedure for patients who have access. There is much work to do, but we're encouraged by the physician and patient feedback so far.'.

贝尔德医疗美洲首席商务官克里斯蒂安·奇尔科特（ChristianChilcott）说，在这个关键时刻加入贝尔德医疗，我非常兴奋至关重要的是，这个市场要了解是什么使MWA更优越，更安全，并且是有机会进入的患者首选的手术方式。还有很多工作要做，但到目前为止，医生和患者的反馈鼓励了我们。”。

Since the inaugural procedure was conducted on January 12th by Dr. Alizera Falahati, there has been a steady increase in the number of procedures successfully conducted in the U.S. by leaders in the field of thyroid disease, including Endocrine Surgeon and Director of Robotic Surgery, Dr. Rasa Zarnegar of Weill Cornell Medicine and Dr.

自1月12日Alizera Falahati博士进行首次手术以来，美国甲状腺疾病领域的领导者成功进行的手术数量稳步增加，包括内分泌外科医生和机器人外科主任，威尔·康奈尔医学的Rasa Zarnegar博士和Dr。

Raymond Yung, an Otolaryngologist and the founder of three specialty clinics in New York City. Dr. Yung practices surgery at NYU Langone Health where he also trains surgical residents. Advocacy from these influential physicians offers a strong testament to the preferred procedural approach that MWA offers to both providers and patients alike..

雷蒙德·容格（RaymondYung），耳鼻喉科医生，纽约市三家专科诊所的创始人。杨博士在纽约大学朗贡健康中心从事外科手术，他还在那里培训外科住院医师。这些有影响力的医生的倡导有力地证明了MWA为提供者和患者提供的首选程序方法。。

On February 2nd, Baird Medical hosted these luminaries and others during the North American Society of Interventional Thyroidology (NASIT) Annual Meeting. NASIT welcomed major medical institutions, including John Hopkins University School of Medicine, Stanford University Medical Center, Columbia University Medical Center, Tulane University Medical Center, Weill Cornell Medicine, and the NYU School of Medicine to deepen industry best practices and develop high-impact relationships..

2月2日，贝尔德医学在北美甲状腺介入学会（NASIT）年会上主办了这些名人和其他人。NASIT欢迎包括约翰·霍普金斯大学医学院、斯坦福大学医学中心、哥伦比亚大学医学中心、杜兰大学医学中心、威尔·康奈尔医学院和纽约大学医学院在内的主要医疗机构深化行业最佳实践，发展高影响力的关系。。

An important aspect of NASIT was convening medical professionals to offer education on employing the MWA procedure to both raise awareness and ensure safety as the technology becomes increasingly available. Baird Medical offers a rigorous medical education program to build industry capacity and safety as a critical part of its business development.

NASIT的一个重要方面是召集医疗专业人员提供关于使用MWA程序的教育，以提高意识并确保随着技术的日益普及而安全。贝尔德医疗提供严格的医学教育计划，以建设行业能力和安全，作为其业务发展的关键部分。

Physician exchange programs have also received positive feedback and fostered high confidence in the new medical procedure..

医生交流计划也收到了积极的反馈，并培养了对新医疗程序的高度信心。。

'We are so glad to receive such positive interest and feedback from our partner physicians who hail from both the Unites States and Europe,' said Ms. Haimei Wu, Founder and CEO of Baird Medical. 'Entering a mature medical market like the United States requires that we take our time to do it well. This means education and safety is the priority.'.

Baird Medical创始人兼首席执行官吴海梅（Haimei Wu）说，我们很高兴收到来自美国和欧洲的合作医生的积极兴趣和反馈进入像美国这样成熟的医疗市场需要我们花时间把它做好。这意味着教育和安全是首要任务。”。

Baird Medical will announce more initiatives in the coming months commensurate with its U.S. commercial expansion.

贝尔德医疗将在未来几个月宣布更多与其美国商业扩张相称的举措。

About Baird Medical

关于Baird Medical

Established in 2012 and headquartered in Guangzhou, China, Baird Medical is a leading microwave ablation (MWA) medical device manufacturer and provider in China and the United States. Baird Medical's proprietary medical devices are used for the treatment of benign and malignant tumors including thyroid nodules, liver cancer, lung cancer and breast lumps.

贝尔德医疗成立于2012年，总部位于中国广州，是中国和美国领先的微波消融（MWA）医疗器械制造商和供应商。贝尔德医疗的专有医疗设备用于治疗良性和恶性肿瘤，包括甲状腺结节、肝癌、肺癌和乳腺肿块。

Baird Medical is the first company to obtain a Class III medical devices registration certificate for MWA medical devices specifically indicated for thyroid nodules in China. For more information, please visit http://baidesz.com/..

贝尔德医疗是中国第一家获得专门针对甲状腺结节的MWA医疗器械III类医疗器械注册证书的公司。有关更多信息，请访问http://baidesz.com/..

Forward-Looking Statements

前瞻性声明

This communication contains 'forward-looking statements.' Such statements include statements concerning anticipated future events and expectations that are not historical facts. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. Forward-looking statements are typically identified by words such as 'believe', 'expect', 'anticipate', 'intend', 'target', 'estimate', 'continue', 'positions', 'plan', 'predict', 'project', 'forecast', 'guidance', 'goal', 'objective', 'prospects', 'possible' or 'potential' by future conditional verbs such as 'assume', 'will', 'would', 'should', 'could' or 'may' or by variations of such words or by similar expressions or the negative thereof.

该通信包含“前瞻性声明”此类声明包括关于预期未来事件和非历史事实预期的声明。除历史事实陈述外的所有陈述均为可被视为前瞻性陈述的陈述。前瞻性陈述通常由诸如“相信”、“期望”、“预期”、“打算”、“目标”、“估计”、“继续”、“立场”、“计划”、“预测”、“项目”、“预测”、“指导”、“目标”、“目标”、“前景”、“可能”或“潜力”等词通过诸如“假设”、“将会”、“将会”、“应该”等未来条件动词来识别，“could”或“may”或此类词语的变体或类似表达或其否定词。

Actual results may vary materially from those expressed or implied by forward-looking statements based on a number of factors. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made. Baird Medical does not assume any obligation to publicly update any forward-looking statement after it is made, whether as a result of new information, future events or otherwise, except as required by law..

实际结果可能与基于多种因素的前瞻性陈述所表达或暗示的结果有很大差异。提醒读者不要过度依赖这些前瞻性声明，这些声明仅在发布之日起生效。贝尔德医疗不承担任何义务，在做出任何前瞻性声明后，无论是由于新信息、未来事件或其他原因，公开更新任何前瞻性声明，除非法律要求。。

Contacts

联系人

Investor RelationsRobin Yang, PartnerICR, LLCPhone: +1 (646) 308-1475Email: [email protected]

投资者关系Robin Yang，PartnerICR，LLC电话：+1（646）308-1475电子邮件：[受电子邮件保护]

Public RelationsBrad Burgess, Senior Vice PresidentICR, LLCPhone: +1 (646) 588-0383Email: [email protected]

公共关系高级副总裁巴德·伯吉斯（Brad Burgess），电话：+1（646）588-0383电子邮件：[受电子邮件保护]

SOURCE Baird Medical Devices, Inc.

来源Baird Medical Devices，Inc。